Training in HIV Psychiatry

2017 ◽  
Author(s):  
David M. Stoff ◽  
Mary Ann Cohen ◽  
Marshall Forstein ◽  
Anna L. Dickerman ◽  
Daena L. Petersen
Keyword(s):  
Diversity Training ◽  
Research Training ◽  
Hiv Treatment ◽  
Aids Education ◽  
Hiv Education ◽  
Prevention Services ◽  
Treatment And Prevention ◽  
Research Workforce ◽  
Living With Hiv ◽  
Hiv Aids

HIV education and training can improve HIV treatment and prevention services, improve HIV-related education, and increase the number of clinicians and investigators working with persons at risk for and living with HIV/AIDS. This chapter presents a biopsychosocial, integrated model of HIV/AIDS education for psychiatry trainees, relevant curriculum and content areas of HIV/AIDS education, and related areas, such as teaching treatment approaches and implementation of training curricula. HIV education is enriched through a balanced approach that emphasizes the importance of diversity training as well as research training. National Institutes of Health (NIH) research training and career development opportunities are highlighted, as are diversity issues in HIV psychiatry for the training of a diverse research workforce.

Progress countering HIV/AIDS in Africa may be at risk

2017 ◽  
Keyword(s):  
At Risk ◽  
Hiv Treatment ◽  
Hiv And Aids ◽  
Sub Saharan Africa ◽  
Content Type ◽  
Prevention Services ◽  
Treatment And Prevention ◽  
Budget Support ◽  
Sub Saharan ◽  
Hiv Aids

Significance HIV and AIDS have slipped from the public radar in recent years but nonetheless remains a serious health challenge across sub-Saharan Africa (SSA). Efforts to control the epidemic may well be put at risk following recent US policy announcements that are likely to undermine prevention efforts. Impacts The US Mexico City Policy will damage HIV/AIDS programming through its effects on critical sexual and reproductive health (SRH) services. Growing drug resistance to HIV treatment will impair both treatment and prevention services, leading to increased deaths and new infections. Weak health systems and lack of domestic support jeopardises the sustainability of HIV services. Emerging health crises may divert donor attention and budget support from HIV/AIDS organisations at a time when momentum is needed.

scholarly journals The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?

2021 ◽  
Vol 20 ◽  
pp. 232595822110090
Author(s):  
Kimberly K. Scarsi ◽  
Susan Swindells
Keyword(s):  
Medication Adherence ◽  
Antiretroviral Therapy ◽  
Hiv Treatment ◽  
Virologic Suppression ◽  
Social Barriers ◽  
Treatment And Prevention ◽  
Undetectable Viremia ◽  
Long Acting ◽  
Available Information ◽  
Living With Hiv

As with other chronic conditions, adherence to daily medications remains a challenge for many individuals living with HIV due to structural, behavioral, and social barriers. Unfortunately, high levels of adherence to antiretroviral therapy are required to maintain virologic suppression. Alternative approaches are being explored to decrease the burden of daily pill administration, including long-acting injectable, oral, and implantable products. Phase 3 data support the efficacy of nanoformulated injectable cabotegravir and rilpivirine for HIV treatment in patients with undetectable viremia, but we have yet to learn how this strategy may benefit those with medication adherence challenges. Despite this, the affected community and HIV providers are very interested in exploring the role of long-acting therapies to address some types of barriers to medication adherence. This review summarizes available information about the potential for long-acting therapy to improve adherence for some patients and outlines associated opportunities and challenges with the implementation of long-acting therapy for the treatment and prevention of HIV.

scholarly journals SWTICH DE ESQUEMAS ANTIRRETROVIRAIS DURANTE A PANDEMIA DE COVID-19 EM UM CENTRO DE REFERÊNCIA DA AMÉRICA LATINA

RAHIS ◽  
2021 ◽  
Vol 18 (4) ◽  
pp. 168-169
Author(s):  
Dirce Inês Silva ◽  
Isabela Estrela Santos ◽  
Jaqueline Xavier Oliveira
Keyword(s):  
Research Society ◽  
Hiv Treatment ◽  
Services Research ◽  
Prevention Services ◽  
Treatment And Prevention ◽  
The Social ◽  
America Latina ◽  
Terapia Antirretroviral ◽  
The Impact ◽  
Brazilian Journal

INTRODUÇÃO : O tratamento da infecção pelo vírus da imunodeficiência humana (HIV) é realizado por meio da terapia antirretroviral (TARV) e vem apresentando avanços importantes no decorrer dos anos. Ocorreu a introdução de novas drogas e classes que ampliaram de modo significativo as opções para o tratamento da infecção pelo HIV-1. Existem razões para a troca (Swtich) da TARV, são eles : manutenção da supressão viral, resistência, probabilidade de maior adesão ao tratamento, eventos adversos, interações medicamentosas (1). Durante a pandemia de Covid-19 que vivenciamos desde março de 2020 no Brasil muitas dificuldades ocorreram nos serviços de saúde, principalmente para as pessoas que vivem com HIV como : acesso aos serviços, diagnóstico, tratamento e acompanhamento (2.3). OBJETIVO: Avaliar a prevalência de trocas de esquemas em um centro de referência da América Latina no período de Janeiro de 2020 a 31 de Julho de 2021.METODOLOGIA : Realizamos um estudo transversal no período de 2020 a 2021 , utilizando o sistema de informação : Sistema de Controle Logístico de Medicamentos (SICLOM) do Ministério da Saúde . Os dados foram analisados no Statistical Package for the Social Science(SPSS® ) 22.RESULTADOS : No período do estudo foram detectadas 473 trocas. Em 2020 ocorreram 283 trocas, 83 em mulheres e 200 em homens. E 2021 até o dia 31/07/2021 foram detectadas 190 trocas, 76 ocorreram em mulheres e 114 em homens. As trocas ocorreram devido : resistência, reações adversas, gestação , tratamento concomitante da tuberculose e simplificação do tratamento ( Figura 1 e 2)).   Figura 1 – Ocorências de Swtich de esquemas antirretroviraisFigura 2- Razões de Trocas de Esquemas Antiretrovirais CONCLUSÃO : Swtich dos esquemas antirretrovirais em utilização pode ser uma estratégia de simplificação da TARV, melhoria da adesão, e em muitos casos a redução de eventos adversos. O arsenal terapêutico no contexto brasileiro é diversificado permitindo uma troca com segurança e sem risco de perda da eficácia virológica. Sendo uma estratégia para enfrentamento da infecção pelo HIV mesmo em tempos de pandemia do COVID19. REFERÊNCIAS:1-Brites, Carlos. Terapia antirretroviral atual: tendências e desafios. Estratégias de troca (switch) naterapia antirretroviral atual. Brazilian Journal of Infectious DiseaseVol 2 . Nº 1 . Fevereiro 20162- Moura, Maria Lucia Costa de. (2020). Coronavírus e COVID-19. Revista Saúde Coletiva, 53, 10.3- Parente, J. da S.; Azevedo, S. L. de .; Moreira, L. da F. A.; Abreu, L. M. .; Souza, L. V. de. The impact of social isolation on the COVID-19 pandemic on access to HIV treatment and prevention services. Research, Society and Development, [S. l.], v. 10, n. 1, p. e28110111692, 2021.  

HIV/AIDS Politics and Policy in Europe

2020 ◽  
Author(s):  
Paul DeBell
Keyword(s):  
Human Rights ◽  
People Living With Hiv ◽  
Health Crisis ◽  
Marginalized Communities ◽  
Leadership Challenges ◽  
Treatment And Prevention ◽  
Increased Risk ◽  
Living With Hiv ◽  
Universal Treatment ◽  
Hiv Aids

HIV/AIDS in Europe highlights the centrality of politics at local, state, and international levels to the successes and failures in fighting transnational, global threats. Though several European states have led the international struggle against HIV/AIDS and have made great strides in treatment and prevention, others host the fastest-growing epidemics in the world. Even in states with long histories of treatment, specific subpopulations, including many LGBTQ communities, face growing epidemics. This variation matches trends in public policy, the actions of political leaders, and social structures of inequity and marginalization toward affected populations. Where leaders stigmatize people living with HIV (PLHIV) and associated groups, the virus spreads as punitive policies place everyone at increased risk of infection. Thus, this epidemic links the health of the general public to the health of the most marginalized communities. Mounting evidence shows that a human rights approach to HIV/AIDS prevention involving universal treatment of all vulnerable communities is essential to combating the spread of the virus. This approach has taken hold in much of Europe, and many European states have worked together as a political force to shape a global human rights HIV/AIDS treatment and prevention regime. Despite this leadership, challenges remain across the region. In some Eastern European states, tragic epidemics are spreading beyond vulnerable populations and rates of transmission continue to rise. The Russian case in particular shows how a punitive state response paired with the stigmatization of PLHIV can lead to a health crisis for the entire country. While scholars have shed light upon the strategies of political legitimization likely driving the scapegoating and stigmatization of PLHIV and related groups, there is an immediate need for greater research in transnational social mobilization to pressure for policies that combat these backward political steps. As financial austerity and defiant illiberalism spread across Europe, key values of universal treatment and inclusion have come into the crosshairs along with the European project more generally. Researchers and policymakers must therefore be vigilant as continued progress in the region is anything but certain. With biomedical advances and the advent of the “age of treatment,” widespread alleviation from the suffering of HIV/AIDS is a real possibility. Realizing this potential will, however, require addressing widespread political, social, and economic challenges. This in turn calls for continued interdisciplinary, intersectional research and advocacy.

scholarly journals Household food security and associated factors among Adult people living with HIV/AIDS attending ART clinic in Hospitals of Hawassa Town, Southern Ethiopia 2018.

2019 ◽  
Author(s):  
REKIKU FIKRE ◽  
Tamirayehu Seyoum habtwelde
Keyword(s):  
Food Security ◽  
Associated Factors ◽  
Dietary Diversity ◽  
Hiv Treatment ◽  
Household Food Security ◽  
Southern Ethiopia ◽  
People Living With Hiv ◽  
Adequate Nutrition ◽  
Living With Hiv ◽  
Hiv Aids

Abstract Abstract Objective Food security and adequate nutrition are fundamental to HIV treatment. There is emerging evidence that patients who begin ART without adequate nutrition have lower survival rates. The relationship between HIV epidemic and food security situation in Ethiopia is complex. Hence, it is likely that the epidemic will contribute to worsening widespread food insecurity. The aim of study was to assess the level of food security and associated factors among adult people living with HIV /AIDS attending ART Clinic in Hospitals of Hawassa city Administration 2018. Results: Based on food security assessment core module scale 360 (67.3%) people living with HIV/AIDS were food insecure. People living with HIV/AIDS who disclose HIV status were 3.9 (AOR=3.902, 95% CI (1.238, 12.301) times more likely to be food secured compared with their counterparts. Subjects with Low Dietary diversity were 4.69 times less likely to be food secured than those with high dietary diversity AOR=4.696, 95% CI (1.536, 14.356). Key words: Food security, disclosures, Household size, Hawassa town.

scholarly journals Stigmatization among People Living with HIV/AIDS at the Kumba Health District, Cameroon

2020 ◽  
Vol 19 ◽  
pp. 232595821989930 ◽  
Author(s):  
Thomas Obinchemti Egbe ◽  
Cynthia Adanze Nge ◽  
Hermann Ngouekam ◽  
Etienne Asonganyi ◽  
Dickson Shey Nsagha
Keyword(s):  
Cross Sectional Study ◽  
Hiv Treatment ◽  
Health District ◽  
People Living With Hiv ◽  
Group Discussions ◽  
Cross Sectional ◽  
Stigma Reduction ◽  
Related Stigma ◽  
Living With Hiv ◽  
Hiv Aids

We determined the level, type of stigma, and risk factors associated with stigmatization of people living with HIV/AIDS (PLWHA) by conducting a cross-sectional study from April to June 2018 in 3 HIV treatment centers in the Kumba Health District (KHD), Cameroon. We reviewed hospital registers, conducted focus group discussions, and administered structured questionnaires. For data analysis, we used the Statistical Package for Social Sciences version 20.0. We recorded a total stigma index score of 59.1. Internal stigma (odds ratio [OR] 2.91; 95% confidence interval [CI]: 1.74-4.98) was common in PLWHA. Also, younger age <30 years (adjusted OR [AOR]: 0.39; 95% CI: 0.17-0.94) was linked with stigma reduction while low level of education (AOR: 1.74; 95% CI: 1.02-2.97) increased the stigma level. HIV-related stigma is pervasive in the lives of PLWHA, with most of them having internal stigmatization. Appropriate health education on HIV will be crucial in reducing stigmatization in the KHD.

scholarly journals Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS

2016 ◽  
Vol 39 (6) ◽  
pp. 1056-1064 ◽  
Author(s):  
Seth C. Kalichman ◽  
Lisa Eaton ◽  
Moira O. Kalichman ◽  
Tama Grebler ◽  
Cynthia Merely ◽  
...  
Keyword(s):  
Treatment Adherence ◽  
Hiv Treatment ◽  
People Living With Hiv ◽  
Medical Mistrust ◽  
Mediation Model ◽  
Medication Beliefs ◽  
Adherence Test ◽  
Living With Hiv ◽  
Hiv Aids
Sign in / Sign up

Export Citation Format

Share Document